Partners & Funders

DRW gratefully acknowledges the support given to us throughout the years by the following organisations:

CHILDREN’S INVESTMENT FUND FOUNDATION (CIFF)

for funding the research and development of SAMBA II instrument and Early Infant Diagnosis (EID) assay as well as their evaluations in Kenya, Malawi, Uganda and Zimbabwe.

FIND

for funding R&D of the SAMBA II Hepatitis C assay.

MEDECINS SANS FRONTIERES

MSF have been a helpful partner to DRW since 2016.

Advising DRW on the diagnostic needs in resource poor settings.
Field-validatation and implementation of SAMBA HIV tests for patient monitoring and early infant diagnosis of HIV at MSF project sites (CAR, Malawi and Uganda).

MEDICAL RESEARCH COUNCIL

for funding clinical evaluations of the SAMBA whole blood based viral load test.

SBIR (Small Business Innovation Reserach) & AIDS Division, National Institutes of Health

for support of technology and product development and clinical evaluations.

INNOVATE UK

for funding the automation of manufacturing process and software development for user interface.

UNITAID

for funding product validation and early implementation of SAMBA assays in Cameroon, Kenya, Malawi, Nigeria, Uganda and Zimbabwe.

WELLCOME TRUST

for funding the research and development of technologies that underpin the SAMBA assays and instruments and related intellecutual properties.

WORLD HEALTH ORGANIZATION (WHO)

for seed funding to establish the Diagnostics Development Unit at the University of Cambridge